Drug · DIN 02292165
DUODOPA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 17, 2013; first marketed November 10, 2008.
- Drug Identification Number (DIN)
- 02292165
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Intraintestinal (Upper)
- Therapeutic class (ATC)
- Levodopa and decarboxylase inhibitor N04BA02
- Class
- Human
- Record last updated
- September 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVODOPA | 20 MG | ML |
| CARBIDOPA (CARBIDOPA MONOHYDRATE) | 5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 23, 2012: NOC 13900New Drug Submission (NDS) · Manufacturer name change
- May 6, 2011: NOC 12314New Drug Submission (NDS) · Change in manufacturer name
- July 15, 2010: NOC 11585New Drug Submission (NDS) · Change in manufacturer name
- March 1, 2007: NOC 8630New Drug Submission (NDS)